These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 25958916)

  • 1. [PET imaging of tau lesions].
    Higuchi M
    Nihon Yakurigaku Zasshi; 2015 May; 145(5):268. PubMed ID: 25958916
    [No Abstract]   [Full Text] [Related]  

  • 2. Dementia in 2014. Towards early diagnosis in Alzheimer disease.
    Nordberg A
    Nat Rev Neurol; 2015 Feb; 11(2):69-70. PubMed ID: 25623789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards development of drugs targeting both amyloid and tau pathologies of Alzheimer's disease.
    Shin J
    Int J Geriatr Psychiatry; 2011 May; 26(5):546-8. PubMed ID: 21446001
    [No Abstract]   [Full Text] [Related]  

  • 4. Biomarkers reflecting different facets of Alzheimer's disease.
    Zetterberg H
    Eur J Neurol; 2008 Nov; 15(11):1143-4. PubMed ID: 18973609
    [No Abstract]   [Full Text] [Related]  

  • 5. New impetus for amyloid-PET imaging following the Food and Drug administration approval of a new Alzheimer's disease treatment.
    Balaji N; Balachandar R; Algodayan S; Lilburn DML; Fraioli F; Bomanji JB
    Nucl Med Commun; 2023 Jun; 44(6):415-416. PubMed ID: 36942553
    [No Abstract]   [Full Text] [Related]  

  • 6. Untangling the relation between beta-amyloid and tau.
    Love R
    Lancet; 2001 Aug; 358(9282):645. PubMed ID: 11530162
    [No Abstract]   [Full Text] [Related]  

  • 7. Commentary: untangling Alzheimer disease pathology.
    Skaper SD
    CNS Neurol Disord Drug Targets; 2015; 14(5):562-3. PubMed ID: 25921862
    [No Abstract]   [Full Text] [Related]  

  • 8. Protein aggregation in Alzheimer's disease: Aβ and τ and their potential roles in the pathogenesis of AD.
    Thal DR; Fändrich M
    Acta Neuropathol; 2015 Feb; 129(2):163-5. PubMed ID: 25600324
    [No Abstract]   [Full Text] [Related]  

  • 9. [Recent study on Alzheimer's disease].
    Hirai S
    Nihon Naika Gakkai Zasshi; 1993 Mar; 82(3):367-71. PubMed ID: 8315330
    [No Abstract]   [Full Text] [Related]  

  • 10. Amyloid-β may be released from non-junctional varicosities of axons generated from abnormal tau-containing brainstem nuclei in sporadic Alzheimer's disease: a hypothesis.
    Braak H; Del Tredici K
    Acta Neuropathol; 2013 Aug; 126(2):303-6. PubMed ID: 23824268
    [No Abstract]   [Full Text] [Related]  

  • 11. Exploiting the Full Potential of β-Amyloid and Tau PET Imaging for Drug Efficacy Testing.
    Barthel H; Seibyl J; Lammertsma AA; Villemagne VL; Sabri O
    J Nucl Med; 2020 Aug; 61(8):1105-1106. PubMed ID: 32414946
    [No Abstract]   [Full Text] [Related]  

  • 12. Power tools for Alzheimer's disease - an electrochemical preamp for Aβ.
    Zetterberg H; Hammarström P
    J Neurochem; 2012 Jul; 122(2):231-2. PubMed ID: 22409410
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial.
    Kullmann DM
    Brain; 2016 May; 139(Pt 5):1311. PubMed ID: 27189576
    [No Abstract]   [Full Text] [Related]  

  • 14. First selective dual inhibitors of tau phosphorylation and Beta-amyloid aggregation, two major pathogenic mechanisms in Alzheimer's disease.
    Mariano M; Schmitt C; Miralinaghi P; Catto M; Hartmann RW; Carotti A; Engel M
    ACS Chem Neurosci; 2014 Dec; 5(12):1198-202. PubMed ID: 25247807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Untangling amyloid-β, tau, and metals in Alzheimer's disease.
    Savelieff MG; Lee S; Liu Y; Lim MH
    ACS Chem Biol; 2013 May; 8(5):856-65. PubMed ID: 23506614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of yeast to study the tau and amyloid-β abnormalities of Alzheimer's disease.
    Porzoor A; Macreadie IG
    J Alzheimers Dis; 2013; 35(2):217-25. PubMed ID: 23396350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau pathology in children and young adults: can you still be unconditionally baptist?
    Duyckaerts C
    Acta Neuropathol; 2011 Feb; 121(2):145-7. PubMed ID: 21225273
    [No Abstract]   [Full Text] [Related]  

  • 18. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
    Bloom GS
    JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What's next for Alzheimer treatment?: while Aβ isn't out of the picture yet, several other therapeutic routes are being explored.
    Schwartz A
    Ann Neurol; 2013 Apr; 73(4):A7-9. PubMed ID: 24643982
    [No Abstract]   [Full Text] [Related]  

  • 20. Monitoring the amyloid beta-peptide in vivo--caveat emptor.
    Thompson PW; Lockhart A
    Drug Discov Today; 2009 Mar; 14(5-6):241-51. PubMed ID: 19135168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.